Elsevier

Schizophrenia Research

Volume 184, June 2017, Pages 143-144
Schizophrenia Research

Letter to the Editor
Valproate induced cerebellar atrophy presenting as movement disorder

https://doi.org/10.1016/j.schres.2016.11.042Get rights and content

Section snippets

Funding source

None.

Conflicts of interest

None.

Acknowledgement

None.

References (7)

  • A. Reif et al.

    Encephalopathy and myoclonus triggered by valproic acid

    Prog. Neuro-Psychopharmacol. Biol. Psychiatry

    (2004)
  • C. Armon et al.

    Reversible parkinsonism and cognitive impairment with chronic valproate use

    Neurology

    (1996)
  • M.J.W. Brennan et al.

    Use of sodium valproate in the management of affective disorders: basic and clinical aspects

There are more references available in the full text version of this article.

Cited by (0)

View full text